CN Stock MarketDetailed Quotes

301211 Hubei Biocause Heilen Pharmaceutical

Watchlist
  • 19.92
  • -1.07-5.10%
Post Market Nov 18 15:00 CST
5.74BMarket Cap53.98P/E (TTM)

Hubei Biocause Heilen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
抗炎类176.25M72.87%
Cardiovascular class32.96M13.63%
Other21.15M8.74%
Antitumor class11.51M4.76%
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Raw material medicine554.61M83.65%
Preparation103.38M15.59%
Other5.04M0.76%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
Territory410.77M61.95%
Overseas252.26M38.05%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data